

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.58630524 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.58630524 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.58630524 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.58630524 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.58630524 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.58630524 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.08319893 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 4.96428011 |
| 9 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.83989677 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.62846383 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.62846383 |
| 12 | DNA deamination (GO:0045006) | 4.60351241 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.51739989 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39103913 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.34679664 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34474074 |
| 17 | detection of other organism (GO:0098543) | 4.28886379 |
| 18 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.23041452 |
| 19 | neutrophil activation (GO:0042119) | 4.17970109 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.15694027 |
| 21 | response to peptidoglycan (GO:0032494) | 4.11589261 |
| 22 | cellular extravasation (GO:0045123) | 4.11264253 |
| 23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.05969038 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92798679 |
| 25 | granulocyte activation (GO:0036230) | 3.87517773 |
| 26 | detection of bacterium (GO:0016045) | 3.80151616 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.79574856 |
| 28 | respiratory burst (GO:0045730) | 3.79185827 |
| 29 | response to host immune response (GO:0052572) | 3.74789783 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.74789783 |
| 31 | detection of biotic stimulus (GO:0009595) | 3.72691806 |
| 32 | microglial cell activation (GO:0001774) | 3.71904808 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.68095750 |
| 34 | myeloid leukocyte mediated immunity (GO:0002444) | 3.46710590 |
| 35 | macrophage activation (GO:0042116) | 3.46393990 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.45682987 |
| 37 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.40920310 |
| 38 | cysteine metabolic process (GO:0006534) | 3.38514125 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.35137264 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.35137264 |
| 41 | response to interleukin-15 (GO:0070672) | 3.34321173 |
| 42 | leukocyte aggregation (GO:0070486) | 3.32552355 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31420109 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.31339858 |
| 45 | response to host (GO:0075136) | 3.31339858 |
| 46 | response to host defenses (GO:0052200) | 3.31339858 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.24835408 |
| 48 | proteasome assembly (GO:0043248) | 3.24626762 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.21694423 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.21694423 |
| 51 | response to type I interferon (GO:0034340) | 3.11418322 |
| 52 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.11270283 |
| 53 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.11014014 |
| 54 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.09794551 |
| 55 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09566198 |
| 56 | valine metabolic process (GO:0006573) | 3.09442607 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08304459 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.07897851 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.07897851 |
| 60 | nucleoside salvage (GO:0043174) | 3.07868408 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.07090286 |
| 62 | formation of translation preinitiation complex (GO:0001731) | 3.06113518 |
| 63 | dendritic cell migration (GO:0036336) | 3.04003103 |
| 64 | leukocyte degranulation (GO:0043299) | 3.00389422 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.98616743 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96671090 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95040869 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93361392 |
| 69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93361392 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93089532 |
| 71 | folic acid metabolic process (GO:0046655) | 2.92617861 |
| 72 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90067920 |
| 73 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.89512964 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88538781 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86843448 |
| 76 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.86760707 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.86280577 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85818174 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84627959 |
| 80 | L-methionine salvage (GO:0071267) | 2.84594004 |
| 81 | L-methionine biosynthetic process (GO:0071265) | 2.84594004 |
| 82 | amino acid salvage (GO:0043102) | 2.84594004 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.84006103 |
| 84 | aldehyde catabolic process (GO:0046185) | 2.82649740 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.81922748 |
| 86 | regulation of tolerance induction (GO:0002643) | 2.80881951 |
| 87 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80588467 |
| 88 | regulation of B cell differentiation (GO:0045577) | 2.73622419 |
| 89 | myeloid leukocyte activation (GO:0002274) | 2.73525953 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.72579479 |
| 91 | negative regulation of interleukin-1 production (GO:0032692) | 2.72428440 |
| 92 | signal peptide processing (GO:0006465) | 2.71492567 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70602000 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69693288 |
| 95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68816519 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68675248 |
| 97 | sulfur amino acid biosynthetic process (GO:0000097) | 2.68533373 |
| 98 | dendritic cell chemotaxis (GO:0002407) | 2.67876679 |
| 99 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.67129764 |
| 100 | immunoglobulin mediated immune response (GO:0016064) | 2.66838050 |
| 101 | response to interferon-alpha (GO:0035455) | 2.66650131 |
| 102 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.65686552 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 2.65254474 |
| 104 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.63900084 |
| 105 | phagosome maturation (GO:0090382) | 2.63883976 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63871893 |
| 107 | purine-containing compound salvage (GO:0043101) | 2.61911617 |
| 108 | pentose-phosphate shunt (GO:0006098) | 2.61878301 |
| 109 | cellular metabolic compound salvage (GO:0043094) | 2.61814775 |
| 110 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61074537 |
| 111 | positive regulation of protein homooligomerization (GO:0032464) | 2.60856920 |
| 112 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60628885 |
| 113 | aromatic amino acid family catabolic process (GO:0009074) | 2.59306931 |
| 114 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.58281756 |
| 115 | lysine metabolic process (GO:0006553) | 2.58157935 |
| 116 | lysine catabolic process (GO:0006554) | 2.58157935 |
| 117 | pyrimidine-containing compound salvage (GO:0008655) | 2.57821208 |
| 118 | pyrimidine nucleoside salvage (GO:0043097) | 2.57821208 |
| 119 | regulation of interleukin-17 production (GO:0032660) | 2.56327304 |
| 120 | cytokine secretion (GO:0050663) | 2.55758213 |
| 121 | defense response to protozoan (GO:0042832) | 2.55727262 |
| 122 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.55396975 |
| 123 | positive regulation of interleukin-8 production (GO:0032757) | 2.54410112 |
| 124 | cellular defense response (GO:0006968) | 2.54285510 |
| 125 | positive regulation of mast cell activation (GO:0033005) | 2.52061016 |
| 126 | I-kappaB phosphorylation (GO:0007252) | 2.51840453 |
| 127 | rRNA modification (GO:0000154) | 2.51783098 |
| 128 | one-carbon metabolic process (GO:0006730) | 2.51747025 |
| 129 | glycine metabolic process (GO:0006544) | 2.51473674 |
| 130 | negative regulation of interleukin-17 production (GO:0032700) | 2.51256302 |
| 131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.50771426 |
| 132 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.50723949 |
| 133 | negative regulation of interleukin-6 production (GO:0032715) | 2.50554076 |
| 134 | cofactor catabolic process (GO:0051187) | 2.50240440 |
| 135 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49547224 |
| 136 | B cell mediated immunity (GO:0019724) | 2.49288422 |
| 137 | glyoxylate metabolic process (GO:0046487) | 2.49163738 |
| 138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.47854597 |
| 139 | ribosomal small subunit assembly (GO:0000028) | 2.47841461 |
| 140 | methionine metabolic process (GO:0006555) | 2.47463289 |
| 141 | methionine biosynthetic process (GO:0009086) | 2.46560056 |
| 142 | NADPH regeneration (GO:0006740) | 2.45323646 |
| 143 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.45271671 |
| 144 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.45271671 |
| 145 | sulfur amino acid catabolic process (GO:0000098) | 2.43832121 |
| 146 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41377975 |
| 147 | oxidative phosphorylation (GO:0006119) | 2.41213468 |
| 148 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.37948340 |
| 149 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.37948340 |
| 150 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.37948340 |
| 151 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.35968525 |
| 152 | negative regulation of ligase activity (GO:0051352) | 2.35968525 |
| 153 | sulfur amino acid metabolic process (GO:0000096) | 2.35641052 |
| 154 | serine family amino acid metabolic process (GO:0009069) | 2.34836240 |
| 155 | nucleotide salvage (GO:0043173) | 2.34048851 |
| 156 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.33565827 |
| 157 | ribosome biogenesis (GO:0042254) | 2.32903834 |
| 158 | regulation of response to interferon-gamma (GO:0060330) | 2.31949267 |
| 159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.31945844 |
| 160 | ribosome assembly (GO:0042255) | 2.30858153 |
| 161 | bile acid biosynthetic process (GO:0006699) | 2.28892540 |
| 162 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.28643787 |
| 163 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.28184119 |
| 164 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.28184119 |
| 165 | S-adenosylmethionine metabolic process (GO:0046500) | 2.28123200 |
| 166 | regulation of cholesterol esterification (GO:0010872) | 2.27798327 |
| 167 | cotranslational protein targeting to membrane (GO:0006613) | 2.27452419 |
| 168 | regulation of protein activation cascade (GO:2000257) | 2.27108272 |
| 169 | pseudouridine synthesis (GO:0001522) | 2.27001268 |
| 170 | purine nucleotide salvage (GO:0032261) | 2.26733985 |
| 171 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.26715322 |
| 172 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.26696351 |
| 173 | oxaloacetate metabolic process (GO:0006107) | 2.26557522 |
| 174 | protein targeting to ER (GO:0045047) | 2.26020958 |
| 175 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.25765761 |
| 176 | complement activation, alternative pathway (GO:0006957) | 2.25677451 |
| 177 | viral transcription (GO:0019083) | 2.25614181 |
| 178 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.24944216 |
| 179 | UMP biosynthetic process (GO:0006222) | 2.24944216 |
| 180 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.24944216 |
| 181 | UMP metabolic process (GO:0046049) | 2.24944216 |
| 182 | protein localization to endoplasmic reticulum (GO:0070972) | 2.24789524 |
| 183 | translational termination (GO:0006415) | 2.24655707 |
| 184 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.24421615 |
| 185 | heme metabolic process (GO:0042168) | 2.23709595 |
| 186 | NIK/NF-kappaB signaling (GO:0038061) | 2.23670084 |
| 187 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22743378 |
| 188 | positive regulation of ligase activity (GO:0051351) | 2.22724229 |
| 189 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.22366159 |
| 190 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.22285223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74906075 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60849620 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59626588 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25969250 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.17109775 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99938217 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93678369 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75933069 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.64051263 |
| 10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.61185644 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.46139091 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.44576083 |
| 13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42087518 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38253784 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.38206730 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36732968 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.30898657 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29538599 |
| 19 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26364254 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19830065 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15657476 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13558132 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11717708 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.04874515 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00483985 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99659254 |
| 27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.91599640 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89635826 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89214643 |
| 30 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88412343 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85033544 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83385953 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81613126 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80071808 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79956956 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76597091 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72712674 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69777572 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69687288 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66461893 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65263832 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.64134800 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63663443 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58735597 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58073502 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58005863 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57266595 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.55539745 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53101494 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.51948709 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50468653 |
| 52 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49331206 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49119192 |
| 54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49048279 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47252720 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.44996809 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44519809 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44413081 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44076257 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41817259 |
| 61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40029258 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39584729 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39172112 |
| 64 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35931270 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.35173834 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.34194677 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33153712 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32496003 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32147645 |
| 70 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.29075284 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28719271 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28685480 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28567026 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28447217 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28127438 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27382763 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26206648 |
| 78 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26052537 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25482421 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24854307 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24722242 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24308563 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24186138 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23909489 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23081419 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20831550 |
| 87 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20700383 |
| 88 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20588360 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19950069 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16996880 |
| 91 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16663185 |
| 92 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.16421241 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15978569 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15773583 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13584079 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12710317 |
| 97 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.11019339 |
| 98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09645971 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07917956 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07670448 |
| 101 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07502873 |
| 102 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07360444 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06731421 |
| 104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06015808 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05417350 |
| 106 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04820165 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02660830 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.02553471 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02042042 |
| 110 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01440802 |
| 111 | MYB_26560356_Chip-Seq_TH2_Human | 1.00330118 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99787997 |
| 113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99517061 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99302575 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97655746 |
| 116 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97169097 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97163063 |
| 118 | MYB_26560356_Chip-Seq_TH1_Human | 0.97060122 |
| 119 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96881841 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96141329 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95786943 |
| 122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94683480 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94673437 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94441858 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94052584 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92617894 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89398541 |
| 128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86901462 |
| 129 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85086051 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82156244 |
| 131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81402754 |
| 132 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81014642 |
| 133 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79522644 |
| 134 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78959630 |
| 135 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77414759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.53210028 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.81472266 |
| 3 | MP0005360_urolithiasis | 3.64690950 |
| 4 | MP0005365_abnormal_bile_salt | 2.97493239 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.75700355 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.72096111 |
| 7 | MP0009840_abnormal_foam_cell | 2.67597583 |
| 8 | MP0003303_peritoneal_inflammation | 2.64761782 |
| 9 | MP0008260_abnormal_autophagy | 2.51757012 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.42690363 |
| 11 | MP0002277_abnormal_respiratory_mucosa | 2.42344736 |
| 12 | MP0003436_decreased_susceptibility_to | 2.27042676 |
| 13 | MP0003186_abnormal_redox_activity | 2.26317206 |
| 14 | MP0009785_altered_susceptibility_to | 2.10949702 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02373280 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.01595662 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 1.97954141 |
| 18 | MP0000685_abnormal_immune_system | 1.96390705 |
| 19 | MP0003724_increased_susceptibility_to | 1.92079877 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.90505200 |
| 21 | MP0005083_abnormal_biliary_tract | 1.89310045 |
| 22 | MP0005671_abnormal_response_to | 1.85611901 |
| 23 | MP0006082_CNS_inflammation | 1.83226366 |
| 24 | MP0003195_calcinosis | 1.77951866 |
| 25 | MP0005332_abnormal_amino_acid | 1.74767038 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.74693599 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.72507663 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.71409331 |
| 29 | MP0005164_abnormal_response_to | 1.70286129 |
| 30 | MP0001853_heart_inflammation | 1.69701672 |
| 31 | MP0005025_abnormal_response_to | 1.66709744 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.66579626 |
| 33 | MP0004883_abnormal_blood_vessel | 1.65716180 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.65607941 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.65302526 |
| 36 | MP0000609_abnormal_liver_physiology | 1.61485874 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.61289420 |
| 38 | MP0004957_abnormal_blastocyst_morpholog | 1.61008332 |
| 39 | MP0001800_abnormal_humoral_immune | 1.60120976 |
| 40 | MP0003828_pulmonary_edema | 1.59218940 |
| 41 | MP0002419_abnormal_innate_immunity | 1.58233614 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.52041538 |
| 43 | MP0008469_abnormal_protein_level | 1.48207719 |
| 44 | MP0002723_abnormal_immune_serum | 1.47921348 |
| 45 | MP0005451_abnormal_body_composition | 1.47484589 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.46545754 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.46545754 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.46005571 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.43429716 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.42260817 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.36972718 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.33950251 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.33748393 |
| 54 | MP0001819_abnormal_immune_cell | 1.33226997 |
| 55 | MP0002398_abnormal_bone_marrow | 1.32737570 |
| 56 | MP0006054_spinal_hemorrhage | 1.32030260 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29983322 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.29963669 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.28586390 |
| 60 | MP0000604_amyloidosis | 1.28214148 |
| 61 | MP0001790_abnormal_immune_system | 1.26484977 |
| 62 | MP0005387_immune_system_phenotype | 1.26484977 |
| 63 | MP0003448_altered_tumor_morphology | 1.24599902 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.24130716 |
| 65 | MP0001764_abnormal_homeostasis | 1.23864952 |
| 66 | MP0009764_decreased_sensitivity_to | 1.23809486 |
| 67 | MP0002405_respiratory_system_inflammati | 1.23313977 |
| 68 | MP0000716_abnormal_immune_system | 1.22552544 |
| 69 | MP0000598_abnormal_liver_morphology | 1.20553496 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.19459421 |
| 71 | MP0002722_abnormal_immune_system | 1.19080328 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.16416432 |
| 73 | MP0009763_increased_sensitivity_to | 1.15230328 |
| 74 | MP0002254_reproductive_system_inflammat | 1.14839827 |
| 75 | MP0002429_abnormal_blood_cell | 1.14765702 |
| 76 | MP0003646_muscle_fatigue | 1.14480746 |
| 77 | MP0000343_altered_response_to | 1.11631891 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.10523262 |
| 79 | MP0004947_skin_inflammation | 1.10275777 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.10167873 |
| 81 | MP0004381_abnormal_hair_follicle | 1.09982463 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 1.08722615 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.06931730 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 1.05824989 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.04040861 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.02613270 |
| 87 | MP0003252_abnormal_bile_duct | 1.02460198 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.00022530 |
| 89 | MP0008057_abnormal_DNA_replication | 1.00022352 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.98939744 |
| 91 | MP0000858_altered_metastatic_potential | 0.97995181 |
| 92 | MP0000490_abnormal_crypts_of | 0.97023220 |
| 93 | MP0005166_decreased_susceptibility_to | 0.96254120 |
| 94 | MP0002933_joint_inflammation | 0.94974977 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.90271808 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.89221203 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.87472050 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87213767 |
| 99 | MP0003786_premature_aging | 0.85567801 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.85444952 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.85114534 |
| 102 | MP0003866_abnormal_defecation | 0.85015834 |
| 103 | MP0003077_abnormal_cell_cycle | 0.84466037 |
| 104 | MP0005266_abnormal_metabolism | 0.84196065 |
| 105 | MP0001851_eye_inflammation | 0.83915746 |
| 106 | MP0002006_tumorigenesis | 0.83313602 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.81946638 |
| 108 | MP0008058_abnormal_DNA_repair | 0.81698408 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.80614386 |
| 110 | MP0001873_stomach_inflammation | 0.80430526 |
| 111 | MP0004130_abnormal_muscle_cell | 0.80241670 |
| 112 | MP0005023_abnormal_wound_healing | 0.80127433 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.79704622 |
| 114 | MP0002971_abnormal_brown_adipose | 0.78371764 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.76724162 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.76461689 |
| 117 | MP0008873_increased_physiological_sensi | 0.76056818 |
| 118 | MP0008004_abnormal_stomach_pH | 0.75856083 |
| 119 | MP0000371_diluted_coat_color | 0.75684696 |
| 120 | MP0005670_abnormal_white_adipose | 0.75284966 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.74160062 |
| 122 | MP0004510_myositis | 0.73736706 |
| 123 | MP0003718_maternal_effect | 0.73184832 |
| 124 | MP0005310_abnormal_salivary_gland | 0.72788109 |
| 125 | MP0003075_altered_response_to | 0.71862162 |
| 126 | MP0002132_abnormal_respiratory_system | 0.70926267 |
| 127 | MP0005174_abnormal_tail_pigmentation | 0.65635148 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.65349691 |
| 129 | MP0005367_renal/urinary_system_phenotyp | 0.61960861 |
| 130 | MP0000516_abnormal_urinary_system | 0.61960861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.15806447 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.09076537 |
| 3 | Stomatitis (HP:0010280) | 4.77088478 |
| 4 | Orchitis (HP:0100796) | 4.73310547 |
| 5 | Optic neuritis (HP:0100653) | 4.69073625 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.69073625 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14086256 |
| 8 | Anorexia (HP:0002039) | 3.68536212 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 3.58531257 |
| 10 | Recurrent skin infections (HP:0001581) | 3.54137583 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.41771252 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.41771252 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.33423725 |
| 14 | Keratoconjunctivitis (HP:0001096) | 3.30382598 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.28207489 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.26512812 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.23602735 |
| 18 | Xanthomatosis (HP:0000991) | 3.18337033 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.15817789 |
| 20 | Encephalitis (HP:0002383) | 3.10855991 |
| 21 | T lymphocytopenia (HP:0005403) | 3.07329002 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.03557999 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.02687727 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 2.99658846 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 2.89198114 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87063968 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 2.86191859 |
| 28 | Multiple enchondromatosis (HP:0005701) | 2.83352254 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82559330 |
| 30 | Obstructive lung disease (HP:0006536) | 2.82559330 |
| 31 | Hypoglycemic coma (HP:0001325) | 2.80727760 |
| 32 | Meningitis (HP:0001287) | 2.80390530 |
| 33 | Leukocytosis (HP:0001974) | 2.78435825 |
| 34 | Hyperammonemia (HP:0001987) | 2.78373557 |
| 35 | Vasculitis (HP:0002633) | 2.77993173 |
| 36 | Hyperlipoproteinemia (HP:0010980) | 2.76294738 |
| 37 | Peritonitis (HP:0002586) | 2.75493830 |
| 38 | Arterial thrombosis (HP:0004420) | 2.75165069 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74243041 |
| 40 | Hepatic necrosis (HP:0002605) | 2.74058124 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 2.74006527 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.72653795 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.70720672 |
| 44 | Hyperalaninemia (HP:0003348) | 2.70720672 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.70720672 |
| 46 | Nausea (HP:0002018) | 2.69496133 |
| 47 | Hemoptysis (HP:0002105) | 2.69159533 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.66912262 |
| 49 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.65156816 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.65086356 |
| 51 | Increased serum ferritin (HP:0003281) | 2.63091082 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.62938430 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.62938430 |
| 54 | Deep venous thrombosis (HP:0002625) | 2.60090949 |
| 55 | Gingivitis (HP:0000230) | 2.58188111 |
| 56 | Abnormality of iron homeostasis (HP:0011031) | 2.57217416 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56961243 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56961243 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56023046 |
| 60 | Episodic fever (HP:0001954) | 2.55979129 |
| 61 | Increased IgM level (HP:0003496) | 2.55834752 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55661355 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.53918771 |
| 64 | Hyperglycinemia (HP:0002154) | 2.49318134 |
| 65 | Abnormality of T cells (HP:0002843) | 2.47499605 |
| 66 | Pulmonary embolism (HP:0002204) | 2.47127657 |
| 67 | Gangrene (HP:0100758) | 2.46777009 |
| 68 | Granulocytopenia (HP:0001913) | 2.46385740 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.46267915 |
| 70 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44979994 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.44386723 |
| 72 | Prolonged partial thromboplastin time (HP:0003645) | 2.39636381 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 2.38620955 |
| 74 | Constricted visual fields (HP:0001133) | 2.37977796 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.35787913 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35074741 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.35074741 |
| 78 | Petechiae (HP:0000967) | 2.34149774 |
| 79 | Complement deficiency (HP:0004431) | 2.33989806 |
| 80 | Ketosis (HP:0001946) | 2.33164111 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32763079 |
| 82 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32604380 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.32507640 |
| 84 | Hyperglycinuria (HP:0003108) | 2.29431012 |
| 85 | Lactic acidosis (HP:0003128) | 2.28456972 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.28189536 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 2.27911155 |
| 88 | Hepatocellular necrosis (HP:0001404) | 2.27906376 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.27016315 |
| 90 | Increased serum lactate (HP:0002151) | 2.25947453 |
| 91 | Chest pain (HP:0100749) | 2.25455534 |
| 92 | Hypochromic anemia (HP:0001931) | 2.25419036 |
| 93 | Eosinophilia (HP:0001880) | 2.24700080 |
| 94 | Abnormal number of erythroid precursors (HP:0012131) | 2.24620679 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24467033 |
| 96 | Cerebral edema (HP:0002181) | 2.23276786 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23181861 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23181861 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23181861 |
| 100 | Acute hepatic failure (HP:0006554) | 2.22636663 |
| 101 | Abnormality of glycine metabolism (HP:0010895) | 2.21867432 |
| 102 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21867432 |
| 103 | Eczematoid dermatitis (HP:0000976) | 2.21051924 |
| 104 | Abnormality of eosinophils (HP:0001879) | 2.20840296 |
| 105 | Increased CSF lactate (HP:0002490) | 2.20377242 |
| 106 | Aplastic anemia (HP:0001915) | 2.19271729 |
| 107 | Single umbilical artery (HP:0001195) | 2.19168697 |
| 108 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.19168697 |
| 109 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.19168697 |
| 110 | Acute encephalopathy (HP:0006846) | 2.18438202 |
| 111 | Lethargy (HP:0001254) | 2.17723036 |
| 112 | Fatigue (HP:0012378) | 2.17540760 |
| 113 | Increased hepatocellular lipid droplets (HP:0006565) | 2.15369649 |
| 114 | Reduced antithrombin III activity (HP:0001976) | 2.14145141 |
| 115 | Pustule (HP:0200039) | 2.13497466 |
| 116 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.10226058 |
| 117 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10007670 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 2.09843622 |
| 119 | Mitochondrial inheritance (HP:0001427) | 2.09833610 |
| 120 | Acanthocytosis (HP:0001927) | 2.08717846 |
| 121 | Microcytic anemia (HP:0001935) | 2.08468337 |
| 122 | Urticaria (HP:0001025) | 2.07887566 |
| 123 | Oral leukoplakia (HP:0002745) | 2.07331202 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 2.07220229 |
| 125 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06729261 |
| 126 | Hypolipoproteinemia (HP:0010981) | 2.06187037 |
| 127 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06122411 |
| 128 | Fat malabsorption (HP:0002630) | 2.04900905 |
| 129 | Purpura (HP:0000979) | 2.04883959 |
| 130 | Recurrent bacterial skin infections (HP:0005406) | 2.04861706 |
| 131 | 3-Methylglutaconic aciduria (HP:0003535) | 2.04639191 |
| 132 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04234457 |
| 133 | Hyperbilirubinemia (HP:0002904) | 2.02908680 |
| 134 | Increased IgE level (HP:0003212) | 2.02464645 |
| 135 | Recurrent abscess formation (HP:0002722) | 2.02178617 |
| 136 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.01493842 |
| 137 | Global brain atrophy (HP:0002283) | 2.01426840 |
| 138 | Exertional dyspnea (HP:0002875) | 2.01347666 |
| 139 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00565408 |
| 140 | Myocardial infarction (HP:0001658) | 1.98423076 |
| 141 | Opisthotonus (HP:0002179) | 1.97692488 |
| 142 | Combined immunodeficiency (HP:0005387) | 1.97047772 |
| 143 | Gingival bleeding (HP:0000225) | 1.96911554 |
| 144 | Acute necrotizing encephalopathy (HP:0006965) | 1.96378327 |
| 145 | Abnormality of the basal ganglia (HP:0002134) | 1.95910790 |
| 146 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95005046 |
| 147 | Keratitis (HP:0000491) | 1.94547344 |
| 148 | Epidermoid cyst (HP:0200040) | 1.93756521 |
| 149 | Thrombophlebitis (HP:0004418) | 1.93669280 |
| 150 | Hepatosplenomegaly (HP:0001433) | 1.92917933 |
| 151 | Recurrent viral infections (HP:0004429) | 1.92336411 |
| 152 | Parakeratosis (HP:0001036) | 1.91979717 |
| 153 | IgM deficiency (HP:0002850) | 1.90350836 |
| 154 | Epistaxis (HP:0000421) | 1.89730636 |
| 155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89287683 |
| 156 | Lymphopenia (HP:0001888) | 1.88844190 |
| 157 | Steatorrhea (HP:0002570) | 1.88835621 |
| 158 | Renal Fanconi syndrome (HP:0001994) | 1.88480527 |
| 159 | Polyneuropathy (HP:0001271) | 1.88006738 |
| 160 | Osteomyelitis (HP:0002754) | 1.87117991 |
| 161 | Glycosuria (HP:0003076) | 1.87067859 |
| 162 | Abnormality of urine glucose concentration (HP:0011016) | 1.87067859 |
| 163 | Axonal loss (HP:0003447) | 1.86941539 |
| 164 | Birth length less than 3rd percentile (HP:0003561) | 1.86138169 |
| 165 | Chronic otitis media (HP:0000389) | 1.85872192 |
| 166 | Autoimmune hemolytic anemia (HP:0001890) | 1.85748078 |
| 167 | Loss of speech (HP:0002371) | 1.84694645 |
| 168 | Abnormality of the peritoneum (HP:0002585) | 1.81490570 |
| 169 | Amaurosis fugax (HP:0100576) | 1.80084825 |
| 170 | Sepsis (HP:0100806) | 1.79887651 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.79505363 |
| 172 | Abnormality of the anterior horn cell (HP:0006802) | 1.79505363 |
| 173 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78825279 |
| 174 | Premature loss of primary teeth (HP:0006323) | 1.75687214 |
| 175 | Skin ulcer (HP:0200042) | 1.75023313 |
| 176 | Toxemia of pregnancy (HP:0100603) | 1.72850645 |
| 177 | Abnormality of the pericardium (HP:0001697) | 1.71708677 |
| 178 | Disinhibition (HP:0000734) | 1.71527677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.89086706 |
| 2 | ERN1 | 3.33220365 |
| 3 | EIF2AK1 | 3.14760412 |
| 4 | BCKDK | 3.07988347 |
| 5 | MAP4K1 | 2.60344296 |
| 6 | KDR | 2.50021874 |
| 7 | TESK2 | 2.48695056 |
| 8 | FGR | 2.47759781 |
| 9 | ACVR1B | 2.37857216 |
| 10 | BLK | 2.37010794 |
| 11 | MAP3K13 | 2.28933773 |
| 12 | ZAP70 | 2.16899886 |
| 13 | WEE1 | 2.01576552 |
| 14 | TYK2 | 1.99612819 |
| 15 | TBK1 | 1.97323135 |
| 16 | TRIM28 | 1.97074534 |
| 17 | EIF2AK3 | 1.94675366 |
| 18 | PIM2 | 1.92045294 |
| 19 | SCYL2 | 1.77717576 |
| 20 | ARAF | 1.77356112 |
| 21 | EPHB1 | 1.70124326 |
| 22 | RIPK4 | 1.65999418 |
| 23 | BUB1 | 1.65055445 |
| 24 | SIK3 | 1.63131806 |
| 25 | PBK | 1.60303951 |
| 26 | CDK19 | 1.59051042 |
| 27 | FLT3 | 1.58989690 |
| 28 | MAP3K11 | 1.58921289 |
| 29 | RPS6KA4 | 1.53093237 |
| 30 | YES1 | 1.53053345 |
| 31 | NEK9 | 1.52134563 |
| 32 | PDK2 | 1.52060564 |
| 33 | TAOK3 | 1.49817627 |
| 34 | FES | 1.49536242 |
| 35 | MAP2K3 | 1.45600770 |
| 36 | MAP3K14 | 1.43363202 |
| 37 | MAP3K3 | 1.41087787 |
| 38 | TXK | 1.39792362 |
| 39 | JAK3 | 1.36878057 |
| 40 | KIT | 1.31381500 |
| 41 | ABL2 | 1.31147580 |
| 42 | FGFR4 | 1.29657409 |
| 43 | BMPR2 | 1.29567557 |
| 44 | RAF1 | 1.29364095 |
| 45 | PAK4 | 1.23335341 |
| 46 | BRSK2 | 1.19948234 |
| 47 | TEC | 1.19166312 |
| 48 | HCK | 1.17698263 |
| 49 | IKBKB | 1.17540555 |
| 50 | IRAK1 | 1.16881935 |
| 51 | STK10 | 1.15712891 |
| 52 | DYRK3 | 1.15707883 |
| 53 | MAPKAPK3 | 1.12971339 |
| 54 | MOS | 1.11001002 |
| 55 | MAP3K2 | 1.10145043 |
| 56 | NLK | 1.07778428 |
| 57 | GRK6 | 1.03869039 |
| 58 | SYK | 1.01624266 |
| 59 | IRAK3 | 1.00279509 |
| 60 | LRRK2 | 0.97463772 |
| 61 | MST4 | 0.97082588 |
| 62 | STK16 | 0.96521231 |
| 63 | IKBKE | 0.95611559 |
| 64 | MAP3K8 | 0.93706341 |
| 65 | KSR1 | 0.93090838 |
| 66 | CDK4 | 0.92326816 |
| 67 | TRIB3 | 0.92272800 |
| 68 | TNK2 | 0.88592586 |
| 69 | BRAF | 0.87640697 |
| 70 | TSSK6 | 0.87308999 |
| 71 | MAP3K1 | 0.87121740 |
| 72 | KSR2 | 0.86689437 |
| 73 | SRPK1 | 0.85908839 |
| 74 | PTK2B | 0.82351761 |
| 75 | MAPK11 | 0.78917483 |
| 76 | NEK2 | 0.78549475 |
| 77 | BCR | 0.78202149 |
| 78 | CLK1 | 0.77728990 |
| 79 | LYN | 0.77074213 |
| 80 | STK24 | 0.76968856 |
| 81 | IRAK2 | 0.75789309 |
| 82 | TAOK1 | 0.75129952 |
| 83 | BTK | 0.74050377 |
| 84 | OXSR1 | 0.73604041 |
| 85 | NME1 | 0.73570376 |
| 86 | CDK8 | 0.72487423 |
| 87 | PLK3 | 0.71475048 |
| 88 | IRAK4 | 0.70946827 |
| 89 | FRK | 0.70734221 |
| 90 | MATK | 0.70017406 |
| 91 | NUAK1 | 0.69466427 |
| 92 | TGFBR1 | 0.69313962 |
| 93 | PIM1 | 0.69105469 |
| 94 | PKN2 | 0.68149134 |
| 95 | MAP3K12 | 0.67233859 |
| 96 | CSF1R | 0.64722451 |
| 97 | LCK | 0.64400966 |
| 98 | GRK7 | 0.64206829 |
| 99 | STK38L | 0.58161021 |
| 100 | STK3 | 0.57756939 |
| 101 | CHUK | 0.57266047 |
| 102 | JAK2 | 0.56679000 |
| 103 | PRKCQ | 0.55878414 |
| 104 | JAK1 | 0.55609806 |
| 105 | CSK | 0.54299905 |
| 106 | TAOK2 | 0.54266711 |
| 107 | BMPR1B | 0.53988533 |
| 108 | MAP3K5 | 0.53202331 |
| 109 | ERBB4 | 0.52540508 |
| 110 | EGFR | 0.51123830 |
| 111 | TGFBR2 | 0.47775053 |
| 112 | CDK7 | 0.47193030 |
| 113 | CDC7 | 0.46585970 |
| 114 | PIK3CG | 0.44621355 |
| 115 | PAK3 | 0.43464814 |
| 116 | MAPKAPK2 | 0.43243572 |
| 117 | TESK1 | 0.43122093 |
| 118 | PRPF4B | 0.42338794 |
| 119 | PLK1 | 0.42186125 |
| 120 | ITK | 0.41112099 |
| 121 | ALK | 0.40676340 |
| 122 | CAMKK2 | 0.39786558 |
| 123 | MAP3K9 | 0.39699284 |
| 124 | MARK3 | 0.38519741 |
| 125 | CDK6 | 0.38033720 |
| 126 | STK4 | 0.37817692 |
| 127 | PRKCD | 0.36327180 |
| 128 | CSNK2A2 | 0.36279073 |
| 129 | VRK1 | 0.36065632 |
| 130 | AURKB | 0.35992325 |
| 131 | NEK6 | 0.35050870 |
| 132 | TLK1 | 0.34685911 |
| 133 | RPS6KB2 | 0.32912720 |
| 134 | SIK1 | 0.32796298 |
| 135 | AURKA | 0.32665704 |
| 136 | CSNK2A1 | 0.32532152 |
| 137 | ABL1 | 0.29659127 |
| 138 | EIF2AK2 | 0.29461941 |
| 139 | PLK2 | 0.29362910 |
| 140 | PAK1 | 0.29062847 |
| 141 | PTK6 | 0.28077763 |
| 142 | TAF1 | 0.27931446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.33794914 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65115474 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.48145054 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36944878 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26607446 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.23652232 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.15397821 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.07374659 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07247836 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04074915 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.02587651 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01047564 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96790406 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93593880 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91167282 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89458813 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.89145418 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.88746560 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83737556 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.83650514 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82372132 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.74397779 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73490244 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.68984032 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67407653 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.67323744 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.67168241 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65653298 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65281888 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64306071 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62465369 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61939190 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.60509538 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57397015 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.56822148 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55717929 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.55216241 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53773480 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52526958 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.50714211 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50315417 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49812129 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47681109 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.47204555 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45544854 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44039732 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39537626 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38141853 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37775817 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36620529 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35542861 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33096638 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31777059 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31707703 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 1.29434607 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27000299 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.25069615 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24522744 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23758508 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21714422 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20127878 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20072400 |
| 63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16461121 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15681916 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15258565 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 1.13980135 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13922097 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12618307 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10871827 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08888828 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08679409 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08565250 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08283981 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07831804 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 1.06666355 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 1.05563836 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04847831 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03536201 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01335497 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00901265 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97913016 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.96127000 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.93519336 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92952581 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92463437 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86483166 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85345305 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84142490 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83851767 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81766621 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.81349047 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80899123 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78327470 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77811830 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77349617 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76471273 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76471065 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.74009634 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72856489 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72696444 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70747240 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69777002 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.69709091 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.69291133 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68930232 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67553686 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66759649 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.64892512 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64149074 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64134966 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64018591 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.63849975 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63524354 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63171158 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63102259 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62931457 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62597943 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59434638 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.57305413 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57012076 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56919415 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56842262 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56722121 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56458516 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53856151 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53109246 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51620247 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51099582 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50467234 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49877549 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.48549014 |
| 132 | RNA degradation_Homo sapiens_hsa03018 | 0.45984203 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45696832 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.45408593 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45361658 |
| 136 | Allograft rejection_Homo sapiens_hsa05330 | 0.45025405 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.44518450 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42236827 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41687251 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41229185 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40672365 |
| 142 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40347137 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39293239 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36446681 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34962965 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31756293 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30401408 |
| 148 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27897465 |
| 149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27775685 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27285098 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26980024 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.25364213 |
| 153 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21723698 |
| 154 | Platelet activation_Homo sapiens_hsa04611 | 0.20317015 |

